Preparation of Monoclonal Antibodies Against Gastrin-Releasing Peptide and Its Inhibition Effect on Breast Cancer Cell in Vitro

WU Guo-jun,WANG Jian-xia,XIE Yan-fei,WU Lin,WU Jie,LIU Jing-jing,LI Tai-ming,CAO Rong-yue
DOI: https://doi.org/10.3969/j.issn.1005-8915.2007.03.004
2007-01-01
Abstract:In order to obtain mouse anti-human GRP monoclonal antibodies and to estimate their inhibition effect on Breast Cancer Cell EMT-6 in vitro,BALB/c mice were immunized with purified recombinant GRP protein as the first step.Then spleen cells from the immunized mice were fused with SP2/0 myeloma cells.Those fused cells were selected by HAT medium and screened by ELISA for obtaining GRP monoclonal antibodies which were identified by ELISA,Western blotting and subtype verification in the next step.Later,this inhibition effect on cancer cells growth was measured by the method of MTT chromatometry.One clone of hybirdoma,named W9,stable in secreting GRP mAbs was obtained through the experiment.This kind of antibodies showed the high specificity to GRP with strong affinity and efficient suppression on proliferation of EMT-6 cells in vitro,so the GRP mAb provided a useful reagent for the clinical diagnosis and the further research.
What problem does this paper attempt to address?